December 20, 2017, Davis, CA. – Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and water treatment markets, announced today that it has signed an exclusive agreement to distribute and market its biofungicide, REGALIA® Maxx with DISAGRO, an international corporation of Guatemalan origin and the leading supplier of agricultural inputs in Central America.
REGALIA Maxx biofungicide stimulates the plant’s innate ability to fight diseases and delivers better yield and improved harvest quality. It is registered in Guatemala, Belize, El Salvador, Honduras, Nicaragua, Costa Rica and Panama, for the control of a wide variety of bacterial and fungal diseases across an array of agricultural crops.
With its exemption from food residue tolerances, Regalia can offer needed residue management benefits to many of the key export crops grown in Central America. Exports in the region totaled US$ 6.75 billion in 2016 according to Central America Data, from key crops such as bananas (US$ 2.39 billion), coffee (US$ 2.38 billion), sugar cane (US$ 1.02 billion) and pineapple (US$ 0.95 billion).
Dr. Pam Marrone, Founder and Chief Executive Officer of Marrone Bio Innovations, commented, “We are proud to add DISAGRO to our growing network of partners. Their focus on technical innovation and operational excellence, combined with their market knowledge and our unique product Regalia Maxx, will provide Central American growers with effective and badly-needed solutions for disease control and yield enhancement.”
DISAGRO is an international corporation of Guatemalan origin and a leading supplier of agricultural fertilizers and other agricultural inputs in Central America. DISAGRO customers are offered a complete portfolio of agricultural inputs and other agro-industrial supplies, including: agricultural fertilizers, crop protection products, animal nutrition products, agricultural and agro-industrial machinery and equipment.
About Marrone Bio Innovations
Bio With Bite.
Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. MBI’s effective and environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health and increasing crop yields. MBI currently has seven commercially available products (Regalia®, Grandevo®, Venerate®, Majestene®, Haven® StargusTM and Zequanox®). MBI also distributes Bio-tam 2.0® for Isagro USA and Jet-Ag® for Jet Harvest in most regions of the U.S.
Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers and consumers around the globe. For more information, please visit www.marronebio.com.
Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding the potential of Regalia and other MBI products in the market in Central America, market projections, including the potential benefits of MBI’s products, and MBI’s plans for expanding additional label uses and international expansion. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets inside and outside the United States, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.
Marrone Bio Innovations Contacts:
Pam Marrone, CEO and Founder
Julie Versman, Dr. Director of International Business
Telephone: +1 (530) 750-2800
MBI Investor Relations:
MZ Group – MZ North America